Literature DB >> 19433682

Is there a standard of care for pathologic stage T3 prostate cancer?

Ian M Thompson, Catherine M Tangen, Eric A Klein.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19433682     DOI： 10.1200/JCO.2008.20.9460

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

1.  Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

Authors:  Robert B Den; Kasra Yousefi; Edouard J Trabulsi; Firas Abdollah; Voleak Choeurng; Felix Y Feng; Adam P Dicker; Costas D Lallas; Leonard G Gomella; Elai Davicioni; R Jeffrey Karnes
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

2.  Postoperative radiotherapy for advanced prostate cancer: improved local control translates into increased survival.

Authors:  Marie-Luise Sautter-Bihl; Felix Sedlmayer; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

3.  Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis.

Authors:  S P Elliott; T J Wilt; K M Kuntz
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-06-21       Impact factor: 5.554

4.  The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

Authors:  Matthew R Cooperberg; Joan F Hilton; Peter R Carroll
Journal:  Cancer       Date:  2011-06-03       Impact factor: 6.860

5.  Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis.

Authors:  T N Showalter; K A Foley; E Jutkowitz; C D Lallas; E J Trabulsi; L G Gomella; A P Dicker; L T Pizzi
Journal:  Ann Oncol       Date:  2011-06-09       Impact factor: 32.976

6.  Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.

Authors:  Prabhakar Mithal; Lauren E Howard; William J Aronson; Martha K Terris; Matthew R Cooperberg; Christopher J Kane; Christopher Amling; Stephen J Freedland
Journal:  BJU Int       Date:  2015-06-23       Impact factor: 5.588

7.  Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.

Authors:  Sarah E Hegarty; Terry Hyslop; Adam P Dicker; Timothy N Showalter
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 8.  Counseling patients about sexual health when considering post-prostatectomy radiation treatment.

Authors:  D Wittmann; J E Montie; D A Hamstra; H Sandler; D P Wood
Journal:  Int J Impot Res       Date:  2009-07-16       Impact factor: 2.896

9.  Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center.

Authors:  Olivier Riou; Pascal Fenoglietto; Benoit Laliberté; Cathy Menkarios; Carmen Llacer Moscardo; Meng Huor Hay; Norbert Ailleres; Jean-Bernard Dubois; Xavier Rebillard; David Azria
Journal:  ISRN Urol       Date:  2012-03-20

10.  Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.

Authors:  Robert B Den; Felix Y Feng; Timothy N Showalter; Mark V Mishra; Edouard J Trabulsi; Costas D Lallas; Leonard G Gomella; W Kevin Kelly; Ruth C Birbe; Peter A McCue; Mercedeh Ghadessi; Kasra Yousefi; Elai Davicioni; Karen E Knudsen; Adam P Dicker
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.